Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 100 shares, a decrease of 50.0% from the October 31st total of 200 shares. Based on an average trading volume of 700 shares, the short-interest ratio is currently 0.1 days.
Aspen Pharmacare Stock Up 1.7 %
Aspen Pharmacare stock traded up $0.16 during mid-day trading on Friday, hitting $9.33. The company’s stock had a trading volume of 371 shares, compared to its average volume of 279. Aspen Pharmacare has a 1 year low of $9.17 and a 1 year high of $13.69. The stock’s fifty day moving average is $10.39 and its two-hundred day moving average is $11.74. The company has a current ratio of 1.81, a quick ratio of 1.07 and a debt-to-equity ratio of 0.30.
Aspen Pharmacare Cuts Dividend
The firm also recently declared a dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were given a $0.1202 dividend. The ex-dividend date was Friday, September 20th.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- Stock Average Calculator
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What is the Euro STOXX 50 Index?
- 3 Penny Stocks Ready to Break Out in 2025
- The Risks of Owning Bonds
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.